Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDCD1 | Q15116 | 1/20 | 0.59 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.59 |
| ▸ | FBP1 | P09467 | 3/20 | 0.55 |
| ▸ | P4HB | P07237 | 13/20 | 0.48 |
| ▸ | GRIN2D | O15399 | 2/20 | 0.43 |
| ▸ | GRIN3B | O60391 | 2/20 | 0.43 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.43 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.43 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.43 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.43 |
| ▸ | GRIN3A | Q8TCU5 | 2/20 | 0.43 |
| ▸ | GSK3B | P49841 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Balazipone SCHEMBL636109 | 0.84 | PDCD1 (0.55) | PDCD1CD274FBP1P4HBGRIN2D | |
| SCHEMBL8039347 | 0.80 | FBP1 (0.54) | FBP1P4HBGSK3B | |
| SCHEMBL9475839 | 0.80 | PDCD1 (0.51) | PDCD1CD274FBP1P4HBGRIN2D | |
| SCHEMBL9475845 | 0.80 | PDCD1 (0.51) | PDCD1CD274FBP1P4HBGRIN2D | |
| SCHEMBL10375509 | 0.79 | PDCD1 (0.71) | PDCD1CD274FBP1 | |
| SCHEMBL10848993 | 0.79 | PDCD1 (0.71) | PDCD1CD274FBP1 | |
| SCHEMBL3115027 | 0.78 | AKR1C3 (0.59) | PDCD1CD274FBP1P4HBGRIN2D | |
| SCHEMBL6981746 | 0.78 | AKR1C3 (0.59) | PDCD1CD274FBP1P4HBGRIN2D | |
| SCHEMBL28372992 | 0.78 | AKR1C3 (0.59) | PDCD1CD274FBP1P4HBGRIN2D | |
| SCHEMBL6947906 | 0.77 | PDCD1 (0.54) | PDCD1CD274FBP1P4HBGRIN2D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0440324-B1 | Substituted beta-diketones and their use in the treatment of inflammatory bowel disease | ORION YHTYMAE OY (FI) | 2000-04-12 | — | — | EP | claimed |
| US-5185370-A | Substituted β-diketones and their use | ORION-YHTYMA OY (FI) | 1993-02-09 | — | — | US | claimed |
| EP-0440324-A2 | Substituted beta-diketones and their use | ORION-YHTYMÀ OY (FI) | 1991-08-07 | — | — | EP | claimed |
| EP-0440324-B1 | Substituted beta-diketones and their use in the treatment of inflammatory bowel disease | ORION YHTYMAE OY (FI) | 2000-04-12 | — | — | EP | disclosed |
| US-5292771-A | Treating inflammatory bowel disease | ORION-YHTYMA OY (FI) | 1994-03-08 | — | — | US | disclosed |
| US-5185370-A | Substituted β-diketones and their use | ORION-YHTYMA OY (FI) | 1993-02-09 | — | — | US | disclosed |
| EP-0440324-A2 | Substituted beta-diketones and their use | ORION-YHTYMÀ OY (FI) | 1991-08-07 | — | — | EP | disclosed |